The lawyer representing a woman in a trial over vaginal mesh implants said manufacturer Johnson & Johnson failed to consider a crucial question concerning the devices — how they could be removed if they cause complications.
As it turned out, the complications affected a number of women. The case being heard in New Jersey Superior Court is the first of about 1,800 lawsuits to go to trial, according to an article ...
continue reading...When Linda Gross of South Dakota had a Gynecare Prolift medical device implanted in 2006, it didn’t have FDA clearance. During her trial against manufacturer Johnson & Johnson, Gross’ lawyer testified that the doctor who performed the operation was unaware of that fact.
According to an article in the Asbury Park Press, her lawyer told the jury: “If he had been warned and given that information, he wouldn’t have used it ...
continue reading...
Johnson & Johnson appointed Andrew Ekdahl to head its orthopaedics division in 2011, a year after the company recalled its ASR artificial hip joints following thousands of complaints that they caused debilitating injuries.
According to the New York Times, the company had billed Ekdahl’s appointment as a fresh start.
The Times reports that Ekdahl had supervised the device’s introduction in the United ...
continue reading...
An orthopedic surgeon testifying at a trial over Johnson & Johnson’s ASR hip implants described tissue colored black with metal debris around the hip joint as the “signature injury” of the devices.
According to a story in the Newark Star Ledger, Dr. Craig Swenson of La Jolla, Calif., refers to the blackened tissue around the artificial hip joints as the “black hole.”
The trial in Los Angeles is the first of 10,000 ...
continue reading...Johnson & Johnson’s earnings for the fourth quarter were better than expected, despite $800 million in expenses related to the company’s recall of its all-metal hip implant.
According to a story in Reuters, the company earned $1.19 per share, excluding one-time items, in the fourth quarter. That beat analysts’ average estimate of $1.17.
The story says the company faces about 2,000 lawsuits related to the “metal-on-metal” hip implant manufactured by Johnson & ...
continue reading...
The U.S. Food and Drug Administration has sent a warning letter to medical device manufacturer St. Jude Medical, warning of problems with manufacturing and quality control at the California plant where the company makes implantable heart defibrillators.
A story in the New York Times notes that the St. Paul-based company has been struggling to deal with problems involving wires that are used to attach the defibrillator to the heart. The wires ...
continue reading...
